Alemtuzumab treatment in Multiple Sclerosis: real clinical experience in the Northwest of Spain

被引：0

作者：

Lopez Real, Ana ^{[1
]}

Gonzalez Suarez, Ines ^{[2
]}

Costa Arpin, Eva ^{[3
]}

Pato Pato, Antonio ^{[4
]}

Alvarez Rodriguez, Elena ^{[2
]}

Rodriguez Regal, Ana ^{[5
]}

Garcia-Pelayo Rodriguez, Ana ^{[1
]}

Garcia Bargo, Maria Dolores ^{[6
]}

Llaneza Gonzalez, Miguel ^{[7
]}

Rodriguez Rodriguez, Maria ^{[8
]}

Solar Sanchez, Dulce Maria ^{[9
]}

Oterino Duran, Agustin ^{[10
]}

Pena Martinez, Joaquin ^{[11
]}

机构：

[1] Univ Hosp A Coruna, Neurol, La Coruna, Spain

[2] Univ Hosp Vigo, Neurol, Vigo, Spain

[3] Univ Hosp Santiago De Compostela, Neurol, Santiago De Compostela, Spain

[4] Povisa Hosp Vigo, Neurol, Vigo, Spain

[5] Univ Hosp Pontevedra, Neurol, Pontevedra, Spain

[6] Univ Hosp Ourense, Neurol, Orense, Spain

[7] Univ Hosp Ferrol, Neurol, Ferrol, Spain

[8] Hosp Lucus Augusti, Lugo, Spain

[9] Univ Hosp Cabuenes, Neurol, Gijon, Spain

[10] Univ Hosp Marques Valdecilla, Neurol, Santander, Spain

[11] Univ Hosp San Agustin, Neurol, Aviles, Spain

来源：

NEUROLOGY | 2018年 / 90卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P6.352

引用

页数：3

共 50 条

[1] Real clinical experience in multiple sclerosis patients treated with alemtuzumab in the Northwest of Spain
Lopez Real, A. M.
Pena Martinez, J.
Rodriguez Regal, A.
Oterino Duran, A.
Solar Sanchez, D. M.
Pato Pato, A.
Gonzalez Suarez, I.
Garcia-Pelayo Rodriguez, A.
Costa Arpin, E.
Llaneza Gonzalez, M. A.
Garcia Bargo, M. D.
Rodriguez Rodriguez, M.
Prieto Gonzalez, J. M.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 851 - 852
[2] Real clinical experience with alemtuzumab in patients with multiple sclerosis in Slovakia
Kantorova, E.
Martinikova, M.
Kianickova, M.
Vitkova, M.
Vitkova, M.
Kovacova, S.
Mako, M.
Hancinova, V.
Lisy, L.
Koleda, P.
Rohalova, J.
Poloniova, J.
Karlik, M.
Slezakova, D.
Klimova, E.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 537 - 537
[3] REAL WORLD EXPERIENCE OF TREATING MULTIPLE SCLEROSIS WITH ALEMTUZUMAB
Khalili, Ellie
Venning, Brent
Boggild, Mike
Broadley, Simon A.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E33 - E33
[4] ALEMTUZUMAB BUDGET IMPACT FOR MULTIPLE SCLEROSIS TREATMENT IN SPAIN
Casellas, M.
Rubio, M.
VALUE IN HEALTH, 2016, 19 (07) : A428 - A428
[5] Alemtuzumab for the treatment of multiple sclerosis
Evan, Jennifer R.
Bozkurt, Subutay B.
Thomas, Nikita C.
Bagnato, Francesca
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (03) : 323 - 334
[6] Alemtuzumab for the treatment of multiple sclerosis
Willis, Mark D.
Robertson, Neil P.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 525 - 534
[7] Alemtuzumab for the treatment of multiple sclerosis
Button, Tom
Coles, Alasdair J.
FUTURE NEUROLOGY, 2010, 5 (02) : 177 - 188
[8] Alemtuzumab Treatment of Multiple Sclerosis
Coles, Alasdair F.
SEMINARS IN NEUROLOGY, 2013, 33 (01) : 66 - 73
[9] Alemtuzumab in the treatment of multiple sclerosis
Fernandez, Oscar
JOURNAL OF INFLAMMATION RESEARCH, 2014, 7 : 19 - 27
[10] Alemtuzumab as Treatment for Multiple Sclerosis
Katsavos, Serafeim
Coles, Alasdair
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (10):

← 1 2 3 4 5 →